Literature DB >> 28804910

T cell protein tyrosine phosphatase prevents STAT1 induction of claudin-2 expression in intestinal epithelial cells.

Moorthy Krishnan1, Declan F McCole1.   

Abstract

T cell protein tyrosine phosphatase (TCPTP) dephosphorylates a number of substrates, including JAK-STAT (signal transducer and activator of transcription) signaling proteins, which are activated by interferon (IFN)-γ, a major proinflammatory cytokine involved in conditions such as inflammatory bowel disease. A critical function of the intestinal epithelium is formation of a selective barrier to luminal contents. The structural units of the epithelium that regulate barrier function are the tight junctions (TJs), and the protein composition of the TJ determines the tightness of the barrier. Claudin-2 is a TJ protein that increases permeability to cations and reduces transepithelial electrical resistance (TER). We previously showed that transient knockdown (KD) of TCPTP permits increased expression of claudin-2 by IFN-γ. Here, we demonstrate that the decreased TER in TCPTP-deficient epithelial cells is alleviated by STAT1 KD. Moreover, increased claudin-2 in TCPTP-deficient cells requires enhanced STAT1 activation and STAT1 binding to the CLDN2 promoter. We also show that mutation of this STAT-binding site prevents elevated CLDN2 promoter activity in TCPTP-deficient epithelial cells. In summary, we demonstrate that TCPTP protects the intestinal epithelial barrier by restricting STAT-induced claudin-2 expression. This is a potential mechanism by which loss-of-function mutations in the gene encoding TCPTP may contribute to barrier defects in chronic intestinal inflammatory disease.
© 2017 New York Academy of Sciences.

Entities:  

Keywords:  barrier function; inflammatory bowel disease; interferon-γ; protein tyrosine phosphatase; tight junction

Mesh:

Substances:

Year:  2017        PMID: 28804910      PMCID: PMC5768570          DOI: 10.1111/nyas.13439

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  58 in total

1.  Superantigen immune stimulation activates epithelial STAT-1 and PI 3-K: PI 3-K regulation of permeability.

Authors:  D M McKay; F Botelho; P J Ceponis; C D Richards
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-11       Impact factor: 4.052

2.  The role of interferon gamma in the pathogenesis of Crohn's disease.

Authors:  T Sasaki; N Hiwatashi; H Yamazaki; M Noguchi; T Toyota
Journal:  Gastroenterol Jpn       Date:  1992-02

Review 3.  The T-cell protein tyrosine phosphatase.

Authors:  M J Ibarra-Sánchez; P D Simoncic; F R Nestel; P Duplay; W S Lapp; M L Tremblay
Journal:  Semin Immunol       Date:  2000-08       Impact factor: 11.130

Review 4.  Protein tyrosine phosphatases as wardens of STAT signaling.

Authors:  Frank-D Böhmer; Karlheinz Friedrich
Journal:  JAKSTAT       Date:  2014-02-20

5.  Loss of protein tyrosine phosphatase N2 potentiates epidermal growth factor suppression of intestinal epithelial chloride secretion.

Authors:  Michael Scharl; Ivan Rudenko; Declan F McCole
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-08-05       Impact factor: 4.052

6.  Claudin-2, a component of the tight junction, forms a paracellular water channel.

Authors:  Rita Rosenthal; Susanne Milatz; Susanne M Krug; Beibei Oelrich; Jörg-Dieter Schulzke; Salah Amasheh; Dorothee Günzel; Michael Fromm
Journal:  J Cell Sci       Date:  2010-05-11       Impact factor: 5.285

7.  STAT6 activation in ulcerative colitis: a new target for prevention of IL-13-induced colon epithelial cell dysfunction.

Authors:  Michael J Rosen; Mark R Frey; M Kay Washington; Rupesh Chaturvedi; Lindsay A Kuhnhein; Poojitha Matta; Frank L Revetta; Keith T Wilson; D Brent Polk
Journal:  Inflamm Bowel Dis       Date:  2011-02-09       Impact factor: 5.325

8.  H. pylori-encoded CagA disrupts tight junctions and induces invasiveness of AGS gastric carcinoma cells via Cdx2-dependent targeting of Claudin-2.

Authors:  Xin Song; Hui-Xin Chen; Xiao-Yan Wang; Xi-Yun Deng; Yin-Xue Xi; Qing He; Tie-Li Peng; Jie Chen; Wei Chen; Benjamin Chun-Yu Wong; Min-Hu Chen
Journal:  Cell Immunol       Date:  2013-11-09       Impact factor: 4.868

9.  Critical role for intracellular calcium in tight junction biogenesis.

Authors:  R O Stuart; A Sun; M Panichas; S C Hebert; B M Brenner; S K Nigam
Journal:  J Cell Physiol       Date:  1994-06       Impact factor: 6.384

10.  Green tea polyphenol (-)-epigallocatechin gallate blocks epithelial barrier dysfunction provoked by IFN-gamma but not by IL-4.

Authors:  James L Watson; Sara Ansari; Heather Cameron; Arthur Wang; Mahmood Akhtar; Derek M McKay
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-07-01       Impact factor: 4.052

View more
  9 in total

1.  The autoimmune susceptibility gene, PTPN2, restricts expansion of a novel mouse adherent-invasive E. coli.

Authors:  Ali Shawki; Rocio Ramirez; Marianne R Spalinger; Paul M Ruegger; Anica Sayoc-Becerra; Alina N Santos; Pritha Chatterjee; Vinicius Canale; Jonathan D Mitchell; John C Macbeth; Casey M Gries; Michel L Tremblay; Ansel Hsiao; James Borneman; Declan F McCole
Journal:  Gut Microbes       Date:  2020-06-26

2.  The JAK-Inhibitor Tofacitinib Rescues Human Intestinal Epithelial Cells and Colonoids from Cytokine-Induced Barrier Dysfunction.

Authors:  Anica Sayoc-Becerra; Moorthy Krishnan; Shujun Fan; Jossue Jimenez; Rebecca Hernandez; Kyle Gibson; Reyna Preciado; Grant Butt; Declan F McCole
Journal:  Inflamm Bowel Dis       Date:  2020-02-11       Impact factor: 5.325

Review 3.  Inflammation-driven brain and gut barrier dysfunction in stress and mood disorders.

Authors:  Ellen Doney; Alice Cadoret; Laurence Dion-Albert; Manon Lebel; Caroline Menard
Journal:  Eur J Neurosci       Date:  2021-05-17       Impact factor: 3.698

4.  Identification of a Novel Susceptibility Marker for SARS-CoV-2 Infection in Human Subjects and Risk Mitigation with a Clinically Approved JAK Inhibitor in Human/Mouse Cells.

Authors:  Marianne R Spalinger; Rong Hai; Jiang Li; Alina N Santos; Tara M Nordgren; Michel L Tremblay; Lars Eckmann; Elaine Hanson; Michael Scharl; Xiwei Wu; Brigid S Boland; Declan F McCole
Journal:  bioRxiv       Date:  2020-12-09

Review 5.  PTPN2 in the Immunity and Tumor Immunotherapy: A Concise Review.

Authors:  Jiachun Song; Jinxin Lan; Jiaping Tang; Na Luo
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

Review 6.  Targeting JAK/STAT signaling pathways in treatment of inflammatory bowel disease.

Authors:  Liang Wang; Yan Hu; Baohui Song; Yongjian Xiong; Jingyu Wang; Dapeng Chen
Journal:  Inflamm Res       Date:  2021-07-01       Impact factor: 4.575

Review 7.  The Role of Protein Tyrosine Phosphatases in Inflammasome Activation.

Authors:  Marianne R Spalinger; Marlene Schwarzfischer; Michael Scharl
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

Review 8.  T Cell Protein Tyrosine Phosphatase in Osteoimmunology.

Authors:  Ya-Nan Wang; Shiyue Liu; Tingting Jia; Yao Feng; Wenjing Zhang; Xin Xu; Dongjiao Zhang
Journal:  Front Immunol       Date:  2021-02-22       Impact factor: 7.561

9.  Loss of protein tyrosine phosphatase non-receptor type 2 reduces IL-4-driven alternative macrophage activation.

Authors:  Marianne R Spalinger; Meli'sa Crawford; Sarah D Bobardt; Jiang Li; Anica Sayoc-Becerra; Alina N Santos; Ali Shawki; Pritha Chatterjee; Meera G Nair; Declan F McCole
Journal:  Mucosal Immunol       Date:  2021-08-21       Impact factor: 7.313

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.